Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review
Abstract
There is an urgent need to develop novel treatment strategies in patients with unfavorable intermediate- and high-risk localized prostate cancer (PCa) to optimize the outcome of these patients. Androgen receptor signaling inhibitors (ARSI) have demonstrated a survival benefit in metastatic hormonesensitive and castration-resistant PCa. A similar benefit might be expected in the localized setting.To perform a systematic review about the role of...
Paper Details
Title
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review
Published Date
Feb 12, 2021
Journal
Volume
39
Issue
9
Pages
3177 - 3185
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History